# Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-analysis-of-1st-through-3rd-line-sequential-targeted-therapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Vakaramoko Diaby,Georges Adunlin,Askal Ayalew Ali,Simon B. Zeichner,Gilberto Lopes,Christine G. Kohn,Alberto J. Montero |
| Citations | 47 |
| DOI | 10.1007/s10549-016-3978-6 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/5329168 |
| OpenAlex ID | https://openalex.org/W2419312609 |
| PMID | 27654970 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Vakaramoko Diaby](https://scholariq.org/researchers/vakaramoko-diaby/)
- [Askal Ayalew Ali](https://scholariq.org/researchers/askal-ayalew-ali/)

## Paper journal

- [Breast Cancer Research and Treatment](https://scholariq.org/journals/breast-cancer-research-and-treatment/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.